Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors
Status: Enrolling
Updated:  3/18/2016
Emory Vision
mi
from
Atlanta, GA
Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors
Status: Enrolling
Updated: 3/18/2016
Emory Vision
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors
Status: Enrolling
Updated:  3/18/2016
Bond Eye Associates
mi
from
Peoria, IL
Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors
Status: Enrolling
Updated: 3/18/2016
Bond Eye Associates
mi
from
Peoria, IL
Click here to add this to my saved trials
Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors
Status: Enrolling
Updated:  3/18/2016
Durrie Vision
mi
from
Overland Park, KA
Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors
Status: Enrolling
Updated: 3/18/2016
Durrie Vision
mi
from
Overland Park, KA
Click here to add this to my saved trials
Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors
Status: Enrolling
Updated:  3/18/2016
TLC Laser Eye Center
mi
from
Greensboro, NC
Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors
Status: Enrolling
Updated: 3/18/2016
TLC Laser Eye Center
mi
from
Greensboro, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors
Status: Enrolling
Updated:  3/18/2016
Memorial Eye Institute
mi
from
Harrisburg, PA
Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors
Status: Enrolling
Updated: 3/18/2016
Memorial Eye Institute
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors
Status: Enrolling
Updated:  3/18/2016
Laser Vision of Texas
mi
from
Houston, TX
Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors
Status: Enrolling
Updated: 3/18/2016
Laser Vision of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors
Status: Enrolling
Updated:  3/18/2016
International Eye Care Laser Center
mi
from
Houston, TX
Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia
Topography-Guided LASIK Using the ALLEGRETTO WAVE Eye-Q 400 Hz Excimer Laser System For the Treatment of Manifest and Cornea Based Myopic and Hyperopic Optical Errors
Status: Enrolling
Updated: 3/18/2016
International Eye Care Laser Center
mi
from
Houston, TX
Click here to add this to my saved trials
Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)
Combination Bevacizumab and Verteporfin (Standard and Reduced Fluence)in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  3/21/2016
California Retina Consultants
mi
from
Bakersfield, CA
Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)
Combination Bevacizumab and Verteporfin (Standard and Reduced Fluence)in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 3/21/2016
California Retina Consultants
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)
Combination Bevacizumab and Verteporfin (Standard and Reduced Fluence)in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated:  3/21/2016
California Retina Consultants
mi
from
Santa Barbara, CA
Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)
Combination Bevacizumab and Verteporfin (Standard and Reduced Fluence)in the Treatment of Neovascular Age-Related Macular Degeneration
Status: Enrolling
Updated: 3/21/2016
California Retina Consultants
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Intervention Trial in Early Age-related Macular Degeneration
Intervention Study to Assess the Effect of Daily Consumption of a Lutein-enriched-egg Beverage on Maintenance of Visual Function in Subjects With Early Signs of Age-related Macular Degeneration
Status: Enrolling
Updated:  3/22/2016
Tufts University
mi
from
Boston, MA
Intervention Trial in Early Age-related Macular Degeneration
Intervention Study to Assess the Effect of Daily Consumption of a Lutein-enriched-egg Beverage on Maintenance of Visual Function in Subjects With Early Signs of Age-related Macular Degeneration
Status: Enrolling
Updated: 3/22/2016
Tufts University
mi
from
Boston, MA
Click here to add this to my saved trials
Intervention Trial in Early Age-related Macular Degeneration
Intervention Study to Assess the Effect of Daily Consumption of a Lutein-enriched-egg Beverage on Maintenance of Visual Function in Subjects With Early Signs of Age-related Macular Degeneration
Status: Enrolling
Updated:  3/22/2016
Universitäts Augenklinik - Bonn
mi
from
Bonn,
Intervention Trial in Early Age-related Macular Degeneration
Intervention Study to Assess the Effect of Daily Consumption of a Lutein-enriched-egg Beverage on Maintenance of Visual Function in Subjects With Early Signs of Age-related Macular Degeneration
Status: Enrolling
Updated: 3/22/2016
Universitäts Augenklinik - Bonn
mi
from
Bonn,
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Winter Haven, FL
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Winter Haven, FL
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Shawnee Mission, KA
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Shawnee Mission, KA
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Wichita, KA
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Boston, MA
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Portsmouth, NH
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Bloomfield, NJ
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Bloomfield, NJ
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Charlotte, NC
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Durham, NC
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Statesville, NC
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Statesville, NC
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Ashland, OR
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Ashland, OR
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
West Columbia, SC
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
West Columbia, SC
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Rapid City, SD
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Rapid City, SD
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Nashville, TN
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Abilene, TX
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Abilene, TX
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Austin, TX
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Harlingen, TX
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Harlingen, TX
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
McAllen, TX
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
McAllen, TX
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
San Antonio, TX
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Willow Park, TX
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Willow Park, TX
Click here to add this to my saved trials
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  3/24/2016
Clinical Research Facility
mi
from
Madison, WI
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
A Phase I Open-Label, Multi-Center Trial With Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 3/24/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Study of Topical Ocular PAN-90806 in PDR
A Phase 1 Open-Label, Single-Center Study to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Proliferative Diabetic Retinopathy (PDR)
Status: Enrolling
Updated:  3/24/2016
Valley Retina Institute
mi
from
Harlingen, TX
Study of Topical Ocular PAN-90806 in PDR
A Phase 1 Open-Label, Single-Center Study to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Proliferative Diabetic Retinopathy (PDR)
Status: Enrolling
Updated: 3/24/2016
Valley Retina Institute
mi
from
Harlingen, TX
Click here to add this to my saved trials
Study of Topical Ocular PAN-90806 in PDR
A Phase 1 Open-Label, Single-Center Study to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Proliferative Diabetic Retinopathy (PDR)
Status: Enrolling
Updated:  3/24/2016
Valley Retina Institute, P.A.
mi
from
McAllen, TX
Study of Topical Ocular PAN-90806 in PDR
A Phase 1 Open-Label, Single-Center Study to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Proliferative Diabetic Retinopathy (PDR)
Status: Enrolling
Updated: 3/24/2016
Valley Retina Institute, P.A.
mi
from
McAllen, TX
Click here to add this to my saved trials
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
High Dose Lucentis for Persistent Pigment Epithelial Detachment in Neovascular Age-related Macular Degeneration - The HiPED Study
Status: Enrolling
Updated:  3/28/2016
Pacific Eye Associates
mi
from
San Francisco, CA
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
High Dose Lucentis for Persistent Pigment Epithelial Detachment in Neovascular Age-related Macular Degeneration - The HiPED Study
Status: Enrolling
Updated: 3/28/2016
Pacific Eye Associates
mi
from
San Francisco, CA
Click here to add this to my saved trials
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
High Dose Lucentis for Persistent Pigment Epithelial Detachment in Neovascular Age-related Macular Degeneration - The HiPED Study
Status: Enrolling
Updated:  3/28/2016
Retina Associates of Kentucky
mi
from
Lexington, KY
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
High Dose Lucentis for Persistent Pigment Epithelial Detachment in Neovascular Age-related Macular Degeneration - The HiPED Study
Status: Enrolling
Updated: 3/28/2016
Retina Associates of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
High Dose Lucentis for Persistent Pigment Epithelial Detachment in Neovascular Age-related Macular Degeneration - The HiPED Study
Status: Enrolling
Updated:  3/28/2016
Tennessee Retina, P.C.
mi
from
Nashville, TN
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
High Dose Lucentis for Persistent Pigment Epithelial Detachment in Neovascular Age-related Macular Degeneration - The HiPED Study
Status: Enrolling
Updated: 3/28/2016
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials
1-Day Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator
A Randomized, Controlled, Double-Masked, Multicenter Trial Designed to Evaluate Acute Tear Production With the Oculeve Intranasal Lacrimal Stimulator Compared to Two Control Applications in Patients With Aqueous Deficient Dry Eye
Status: Enrolling
Updated:  3/28/2016
The Eye Care Group, PC
mi
from
Waterbury, CT
1-Day Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator
A Randomized, Controlled, Double-Masked, Multicenter Trial Designed to Evaluate Acute Tear Production With the Oculeve Intranasal Lacrimal Stimulator Compared to Two Control Applications in Patients With Aqueous Deficient Dry Eye
Status: Enrolling
Updated: 3/28/2016
The Eye Care Group, PC
mi
from
Waterbury, CT
Click here to add this to my saved trials
1-Day Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator
A Randomized, Controlled, Double-Masked, Multicenter Trial Designed to Evaluate Acute Tear Production With the Oculeve Intranasal Lacrimal Stimulator Compared to Two Control Applications in Patients With Aqueous Deficient Dry Eye
Status: Enrolling
Updated:  3/28/2016
Virginia Eye Consultants
mi
from
Norfolk, VA
1-Day Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator
A Randomized, Controlled, Double-Masked, Multicenter Trial Designed to Evaluate Acute Tear Production With the Oculeve Intranasal Lacrimal Stimulator Compared to Two Control Applications in Patients With Aqueous Deficient Dry Eye
Status: Enrolling
Updated: 3/28/2016
Virginia Eye Consultants
mi
from
Norfolk, VA
Click here to add this to my saved trials
Effect of Osteopathic Cranial Manipulative Medicine on Visual Function
Effect of Osteopathic Cranial Manipulative Medicine on Visual Function
Status: Enrolling
Updated:  3/30/2016
Nova Southeastern University Davie Health Center
mi
from
Ft. Lauderdale, FL
Effect of Osteopathic Cranial Manipulative Medicine on Visual Function
Effect of Osteopathic Cranial Manipulative Medicine on Visual Function
Status: Enrolling
Updated: 3/30/2016
Nova Southeastern University Davie Health Center
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated:  3/31/2016
Univerisity of Miami Bascom Palmer Eye Institute
mi
from
Miami, FL
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated: 3/31/2016
Univerisity of Miami Bascom Palmer Eye Institute
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated:  3/31/2016
Kraff Eye Institute
mi
from
Chicago, IL
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated: 3/31/2016
Kraff Eye Institute
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated:  3/31/2016
Pepose Vision Institute
mi
from
Chesterfield, MO
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated: 3/31/2016
Pepose Vision Institute
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated:  3/31/2016
Durrie Vision
mi
from
Kansas City, MO
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated: 3/31/2016
Durrie Vision
mi
from
Kansas City, MO
Click here to add this to my saved trials
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated:  3/31/2016
Coleman Vision
mi
from
Albuquerque, NM
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated: 3/31/2016
Coleman Vision
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated:  3/31/2016
Lehmann Eye Center
mi
from
Nacogdoches, TX
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated: 3/31/2016
Lehmann Eye Center
mi
from
Nacogdoches, TX
Click here to add this to my saved trials
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated:  3/31/2016
The Eye Center
mi
from
Fairfax, VA
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated: 3/31/2016
The Eye Center
mi
from
Fairfax, VA
Click here to add this to my saved trials
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated:  3/31/2016
King LASIK
mi
from
Renton, WA
Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed Astigmatism
A Prospective Study to Evaluate the Safety and Effectiveness of Wavefront-Guided LASIK Correction of Mixed Astigmatic Refractive Errors With the iDESIGN Advanced Wavescan Studio™ System and STAR S4 IR™ Excimer Laser System
Status: Enrolling
Updated: 3/31/2016
King LASIK
mi
from
Renton, WA
Click here to add this to my saved trials
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT
Retrospective, Uncontrolled, Multicenter, Case History Study to Determine the Natural History of Visual Function in Subjects With Inherited Retinal Disease (IRD) Caused by Inherited Mutation of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Status: Enrolling
Updated:  3/31/2016
The Wilmer Eye Institute, Johns Hopkins Hospital
mi
from
Baltimore, MD
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT
Retrospective, Uncontrolled, Multicenter, Case History Study to Determine the Natural History of Visual Function in Subjects With Inherited Retinal Disease (IRD) Caused by Inherited Mutation of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT)
Status: Enrolling
Updated: 3/31/2016
The Wilmer Eye Institute, Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials